In In Re Affinity Labs of Texas, LLC, [2016-1092, 2016-1172] (May 5, 2017) the Federal Circuit affirmed the Board’s affirmance of a reexamination determination that all of the claims of U.S. Patent No. 7,324,833 was invalid. The Board merged two inter partes … Continue reading Estoppel Under 317(b) Always Applies on a Claim by Claim Basis, Just Like the Statute Says